p21 promotes error-free replication-coupled DNA double-strand break repair
Open accessThe DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index.
Abstract
p21 is a well-established regulator of cell cycle progression. The role of p21 in DNA repair, however, remains poorly characterized. Here, we describe a critical role of p21 in a replication-coupled DNA double-strand break (DSB) repair that is mechanistically distinct from its cell cycle checkpoint function. We demonstrate that p21-deficient cells exhibit elevated chromatid-type aberrations, including gaps and breaks, dicentrics and radial formations, following exposure to several DSB-inducing agents. p21-/- cells also exhibit an increased DNA damage-inducible DNA-PKCS S2056 phosphorylation, indicative of elevated non-homologous DNA end joining. Concomitantly, p21-/- cells are defective in replication-coupled homologous recombination (HR), exhibiting decreased sister chromatid exchanges and HR-dependent repair as determined using a crosslinked GFP reporter assay. Importantly, we establish that the DSB hypersensitivity of p21-/- cells is associated with increased cyclin-dependent kinase (CDK)-dependent BRCA2 S3291 phosphorylation and MRE11 nuclear foci formation and can be rescued by inhibition of CDK or MRE11 nuclease activity. Collectively, our results uncover a novel mechanism by which p21 regulates the fidelity of replication-coupled DSB repair and the maintenance of chromosome stability distinct from its role in the G1-S phase checkpoint.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this regard, it should be mentioned that, in a manner that depends on CDK inactivation, p21 was reported to regulate the homologous recombination-mediated repair of double-strand-breaks (DSBs), a DNA lesion that is induced by γ irradiation [72].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · cited 1×
“If inappropriately repaired, DSBs have the potential to lead to cell death or cellular transformation, the first step in cancer formation (1).”
BackgroundRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 1×
“HCT116 wild-type, p21 / and p53 / cells (6,7) were grown in McCoy’s 5A medium.”
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · cited 1×
“The p21 protein is a member of a family of cyclin-dependent kinase (CDK) inhibitors and is a major regulator of cell cycle progression (5).”
Background53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671
Schlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,255 · cited 3×
“In the absence of BRCA2, or RAD51, inadvertent MRE11 nuclease activity promotes fork degradation and chromosome instability (24,33).”
BackgroundSelf-citationRequirement of the MRN complex for ATM activation by DNA damage
Uziel, T., Lerenthal, Y., Moyal, L., Andegeko, Y., Mittelman, L., & Shiloh, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg541 · Cited by 1,075 · cited 1×
“First, we examined the recruitment of the MRE11 nuclease, a protein known to play a very early role in the sensing and nucleolytic processing of DSBs and in the choice of HR and NHEJ pathways (17).”
MethodSae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing
Mimitou, E. P., & Symington, L. S. (2008) · Nature · doi:10.1038/nature07312 · Cited by 1,007
Bouwman, P., Aly, A., Escandell, J. M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1831 · Cited by 1,001
Haber, J. E. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02022-9 · Cited by 563
Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis
Hashimoto, Y., Ray Chaudhuri, A., Lopes, M., & Costanzo, V. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1927 · Cited by 548 · cited 2×
“In the absence of BRCA2, or RAD51, inadvertent MRE11 nuclease activity promotes fork degradation and chromosome instability (24,33).”
Background
Cited by
p21: a two-faced genome guardian.
Georgakilas, A. G., Martin, O. A., & Bonner, W. M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.001 · Cited by 489
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Kreis, N.-N., Louwen, F., & Yuan, J. (2019) · Cancers · doi:10.3390/cancers11091220 · Cited by 298
“Apoptosis inhibition/activation Both Oncogene/Tumor suppressor [51,52] Autophagy induction/inhibition Cytoplasm ? [54,56] Cell cycle arrest Nucleus Tumor suppressor [1,18] Cell cycle progression Cytoplasm Oncogene [37,39] Chromosomal stability Nucleus Tumor suppressor [23–25] Differentiation Both Both [63,64] DNA synt…”
BackgroundDutto, I., Tillhon, M., Cazzalini, O., Stivala, L. A., & Prosperi, E. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1430-4 · Cited by 236
Al Bitar, S., & Gali-Muhtasib, H. (2019) · Cancers · doi:10.3390/cancers11101475 · Cited by 224
Role of AKT signaling in DNA repair and clinical response to cancer therapy
Liu, Q., Turner, K. M., Alfred Yung, W. K., Chen, K., & Zhang, W. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou058 · Cited by 140
“p21-mediated inhibition of CDK activity interrupts CDKmediated BRCA2 S3291 phosphorylation and thus facilitates the interaction between RAD51 and the carboxy-terminus of BRCA2 that promotes HR DNA repair.(94) AKT regulates CDK activity via the CDK inhibitors p21 and p27.”
BackgroundAnuranjani, & Bala, M. (2014) · Redox Biology · doi:10.1016/j.redox.2014.02.008 · Cited by 143
Role of Rad51 and DNA repair in cancer: A molecular perspective
Laurini, E., Marson, D., Fermeglia, A., Aulić, S., Fermeglia, M., & Pricl, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107492 · Cited by 141
CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114
“In this regard, it should be mentioned that, in a manner that depends on CDK inactivation, p21 was reported to regulate the homologous recombination-mediated repair of double-strand-breaks (DSBs), a DNA lesion that is induced by γ irradiation [72].”
BackgroundCheckpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
Isono, M., Hoffmann, M. J., Pinkerneil, M., Sato, A., Michaelis, M., Cinatl, J. J., Niegisch, G., & Schulz, W. A. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0473-1 · Cited by 87
“p21 promotes HR by inhibiting cyclin dependent kinases (CDK), since increased CDK activity in the absence of p21 is associated with elevated levels of DNA damage [41].”
BackgroundTicli, G., Cazzalini, O., Stivala, L. A., & Prosperi, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137058 · Cited by 76
“However, a mechanism to promote HR by CDK inhibition, as reported above [84], may also be envisaged.”
BackgroundInfluentialMartin, J. W., Chilton‐MacNeill, S., Koti, M., van Wijnen, A. J., Squire, J. A., & Zieleńska, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095843 · Cited by 56
“CDKN1A is activated in response to activation of the ATM/TP53 DNA damage checkpoint that accommodates double-stranded DNA repair and inhibits cell cycle progression by CDK4 [54], MDM2 is an inhibitor of TP53 [55], BCL2L1 is an anti-apoptotic factor [56], PTEN is a tumor suppressor commonly lost in osteosarcomas [23],…”
BackgroundP21-PARP-1 Pathway Is Involved in Cigarette Smoke-Induced Lung DNA Damage and Cellular Senescence
Yao, H., Sundar, I. K., Gorbunova, V., & Rahman, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080007 · Cited by 45
“[41,43,44].”
ResultMansilla, S. F., Bertolin, A. P., Bergoglio, V., Pillaire, M.-J., González Besteiro, M. A., Luzzani, C., Miriuka, S. G., Cazaux, C., Hoffmann, J.-S., & Gottifredi, V. (2016) · eLife · doi:10.7554/elife.18020 · Cited by 43
“While such p21 function has been linked to CDK inhibition (Mauro et al., 2012), it is still possible that the loading of p21 to PCNA serves to orchestrate multiple transactions at the elongating DNA.”
BackgroundMohapatra, P., Satapathy, S. R., Das, D., Siddharth, S., Choudhuri, T., & Kundu, C. N. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.01.011 · Cited by 40
“, 2000; Kavurma and Khachigian, 2003), and DNA damage repair (Chen et al., 1996; Mauro et al., 2012; Oku et al., 1998; Podust et al., 1994;Waga et al., 1994).”
BackgroundMultiple functions of p21 in cancer radiotherapy
Kuang, Y., Kang, J. L., Li, H., Liu, B., Zhao, X., Li, L., Jin, X., & Li, Q. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03529-2 · Cited by 39
Hung, F.-M., Chen, Y., Huang, A., Hsiao, Y., Yang, J., Chung, M.-T., Chueh, F., Lu, H.-F., & Chung, J. (2013) · Oncology Reports · doi:10.3892/or.2013.2230 · Cited by 37
“It has been reported that p21 is a well-characterized CDK inhibitor; high levels of p21 can inhibit cyclin D1 expression, resulting in the decline of pRb phosphorylation (39,40).”
Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition
Kreis, N., Louwen, F., Zimmer, B., & Yuan, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2844 · Cited by 33
“Consequently, non-severe DNA damage induces the expression of p21, which causes a cell cycle arrest [35,36] and favors an efficient DNA repair [25,37,38], resulting in a resumed cell cycle.”
BackgroundCIP/KIP and INK4 families as hostages of oncogenic signaling
Csergeová, L., Krbušek, D., & Janoštiak, R. (2024) · Cell Division · doi:10.1186/s13008-024-00115-z · Cited by 33
“…the formation of complexes of PCNA with DNA repair machinery that leads to impairment of mismatch repair [20]. p21CIP accumulates also on the sites of double-strand breaks and promotes homologous recombination (HR) or non-homologous end joining (NHEJ) depending on the cell cycle phase [21, 22].”
BackgroundTopoisomerase I inhibitor, camptothecin, induces apoptogenic signaling in human embryonic stem cells
García, C. P., Videla-Richardson, G. A., Romorini, L., Miriuka, S., Sevlever, G. E., & Scassa, M. É. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.12.002 · Cited by 33
Woodard, K. J., Doerfler, P. A., Mayberry, K. D., Sharma, A., Levine, R. M., Yen, J. S., Valentine, V. A., Palmer, L. E., Valentine, M. B., & Weiss, M. J. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049463 · Cited by 27
“3F) (Georgakilas et al., 2017; Mauro et al., 2012).”
Giordano, C., Rovito, D., Barone, I., Mancuso, R., Bonofiglio, D., Giordano, F., Catalano, S., Gabriele, B., & Andò, S. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.01.006 · Cited by 27
Zeng, Z., Du, H., Xiong, L., Zeng, X.-L., Zhang, P., Cai, J., Huang, L., & Liu, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117342 · Cited by 26
Bimodal regulation of p21waf1protein as function of DNA damage levels
Buscemi, G., Ricci, C., Zannini, L., Fontanella, E., Plevani, P., & Delia, D. (2014) · Cell Cycle · doi:10.4161/15384101.2014.946852 · Cited by 26
“Furthermore, p21 was described as an important factor in DNA damage-induced senescence(7) and, more recently, as a regulator of DSBs repair.(8) It is generally assumed that, in response to DNA damage, p53 induces the transcription and accumulation of the p21 protein, thus promoting cell cycle arrest and, eventually, a…”
BackgroundIsono, M., Okubo, K., Asano, T., & Sato, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-89684-5 · Cited by 24
Mirzayans, R., Andrais, B., Scott, A., Wang, Y., Weiss, R. H., & Murray, D. L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511609 · Cited by 23
“In addition to its pivotal role in activating cell cycle checkpoints, downregulating apoptosis and inducing premature senescence, the p21 protein is recruited by γH2AX to DSB sites in genomic DNA [56–59] and promotes the replication-coupled repair of DSBs [59].”
BackgroundVendetti, F. P., Leibowitz, B. J., Barnes, J., Schamus, S., Kiesel, B. F., Abberbock, S. R., Conrads, T. P., Clump, D. A., Cadogan, E. B., O’Connor, M. J., et al. (2017) · Scientific Reports · doi:10.1038/srep41892 · Cited by 22
Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer
Wyatt, G. L., Crump, L. S., Young, C., Wessells, V. M., McQueen, C. M., Wall, S. W., Gustafson, T. L., Fan, Y., Chapkin, R. S., Porter, W. W., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1224-y · Cited by 21
Liu, Q., Chen, C., & Chen, G. (2020) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2020.3957 · Cited by 20
“25,26 Cyclin D1 is crucial to cell cycle regulation and can exert oncogenic effects in numerous human cancers, including EC.”
Heidari, Z., Harati‐Sadegh, M., Arian, A., Maruei‐Milan, R., & Salimi, S. (2020) · IUBMB Life · doi:10.1002/iub.2225 · Cited by 19
“The p21 protein is a cyclin-dependent kinase (CDK) inhibitor and is able to block replication of DNA by triggering the PCNA and inhibit progression of cell cycle.(10,11) It has been reported that the pathway of p53/p21 is inactivated in more than half of all cancers.”
BackgroundPeega, T., Magwaza, R. N., Harmse, L., & Kotzé, I. A. (2021) · Dalton Transactions · doi:10.1039/d1dt01385h · Cited by 18
ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways
Guo, Q., Pin, G., Mao, Q., Lan, J., Lin, Y., Jiang, J., & Qiu, Y. (2013) · Medical Oncology · doi:10.1007/s12032-012-0325-6 · Cited by 17
Kim, H., Kim, H.-I., Jang, E., Eom, Y. W., Yoon, G., Choi, K. S., & Kim, E. H. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02416-w · Cited by 17
Strzeszewska, A., Staniak, K., Czarnecka‐Herok, J., Rafiee, M., Herok, M., Mosieniak, G., Krijgsveld, J., & Sikora, E. (2021) · Cancers · doi:10.3390/cancers13092115 · Cited by 18
Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells
Isono, M., Sato, A., Asano, T., Okubo, K., & Asano, T. (2018) · Anticancer Research · doi:10.21873/anticanres.12908 · Cited by 13
Li, H., Tian, Y., Li, X., Wang, B., Zhai, D., Bai, Y., Dong, C., & Xu, C. (2019) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15426261956343 · Cited by 13
García, C. P., Videla-Richardson, G. A., Dimopoulos, N. A., Espinosa, D. D. F., Miriuka, S., Sevlever, G. E., Romorini, L., & Scassa, M. É. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152607 · Cited by 13
“It thus appears that despite the similar cell cycle distribution and the presence of p21 which plays a central role in the coordination of early steps of DNA replication coupled to DSBs repair triggered by CPT [41], additional cell-type specific mechanisms may operate to ultimately dictate cell fate along development.”
BackgroundMarrelli, M., Giordano, F., Perri, M. R., Amodeo, V., Baldino, N., Lupia, C., Uzunov, D., Musolino, V., Conforti, F., & Panno, M. L. (2023) · Antioxidants · doi:10.3390/antiox12020384 · Cited by 12
“In the presence of certain stressors, p21 can induce intrinsic and extrinsic pathways of apoptosis, with an increase in the proapoptotic protein Bax and activation of the tumor necrosis factor (TNF) family of death receptors, respectively [54,56].”
Olaparib combined with CDK12-IN-3 to promote genomic instability and cell death in ovarian cancer
Liang, J., Zhou, X., Yuan, L., Chen, T., Wan, Y., Jiang, Y., Meng, H., Xu, M., Zhang, L., & Cheng, W. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.94568 · Cited by 12
“Significantly, p21 prevents CDK-mediated phosphorylation of BRCA2 S3291, thus destabilizes RAD51-BRCA2 complex and decreases replication-coupled HR capacity, which is independent of its negative role in cell cycle progression [58] .”
BackgroundPaviolo, N. S., de la Vega, M. B., Pansa, M. F., García, I. A., Calzetta, N. L., Soria, G., & Gottifredi, V. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2019-0070 · Cited by 12
“It should be also mentioned that p21 deficiency negatively regulates BRCA2-mediated repair of replication-coupled DSBs (Mauro et al., 2012), which could be relevant for controling BRCA1 deficient but not BRCA2 deficient cells.”
BackgroundDu, Y., Hu, P., Ding, X., Wang, D., Luo, J., Le, S., Ren, L., Chen, M., Ye, P., & Xia, J. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70147 · Cited by 11
Lamartine-Hanemann, S. D. S., Ferreira‐Silva, G. Á., Horvath, R. D. O., Soncini, R., Caixeta, E. S., Rocha-Sales, B., Niero, E. L. D. O., Machado‐Santelli, G. M., dos Santos, M. H., de Oliveira, J. C., et al. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104927 · Cited by 10
UHRF2 promotes DNA damage response by decreasing p21 via RING finger domain
Wang, Y., Yan, X., Zeng, S., Zhang, T., Cheng, F., Chen, R., & Duan, C. (2018) · Biotechnology Letters · doi:10.1007/s10529-018-2577-5 · Cited by 10
Assessing Cell Cycle Independent Function of the CDK Inhibitor p21CDKN1A in DNA Repair
Dutto, I., Tillhon, M., & Prosperi, E. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2926-9_11 · Cited by 10
The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update
Tiucă, R. A., Tiucă, O. M., & Pascanu, I. M. (2023) · Biomedicines · doi:10.3390/biomedicines11041075 · Cited by 9
“The p21 protein is a cyclin-dependent kinase inhibitor that is expressed by the activated TP53 during the G1 phase of the cell cycle, inhibiting DNA replication and therefore stopping the progression of the cell cycle [35].”
BackgroundCoping with DNA Double-Strand Breaks via ATM Signaling Pathway in Bovine Oocytes
Wang, L., Xu, X., Teng, M., Zhao, G., & Lei, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238892 · Cited by 8
“It has also been recently reported that p21 promotes DNA DSBs repair [57].”
BackgroundHu, Y., Bao, Q., Huang, Y., Wang, Y., Zhao, X., Nan, J., Meng, Y., Deng, M., Li, Y., Zhuang, Z., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci195538 · Cited by 5
“Poly(ADP-ribose) glycohydrolase enforces p21 degradation via dePARylation to promote gastric cancer progression”
Li, L., Wu, Y., Huang, H.-T., Yong, J., Lv, Z., Zhou, Y. Y., Xiang, X., Zhao, J., Xi, Z., Feng, H., et al. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05858-4 · Cited by 4
“Functionally, p21 plays a multifaceted role in orchestrating cell cycle arrest, facilitating DNA repair, and regulating apoptosis (Mauro et al. 2012; Gartel and Tyner 2002).”
BackgroundZhu, Y. Q., Lei, Y., Du, B., Zheng, Y., Lu, X., Tan, T., Kang, J., Sun, L., & Liang, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115704 · Cited by 4
“p21 is a key factor regulated by p53 in response to DNA damage [3, 4], accumulating in cell nucleus owing to increasing gene expression after DNA damage.”
BackgroundModular Nanotransporter with P21 Fragment Inhibits DNA Repair after Bleomycin Treatment
Kamaletdinova, T., Rosenkranz, A. A., Ulasov, A. V., Khramtsov, Y. V., Tsvetkova, A. D., Georgiev, G. P., & Sobolev, A. S. (2018) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672918020114 · Cited by 4
Hildebrand, L. S., Jost, T., Schindler, M., Derer, A., Fuhrmann, G., Fietkau, R., & Distel, L. V. (2025) · Scientific Reports · doi:10.1038/s41598-025-03159-5 · Cited by 3
“CDKN1A upregulation could be an explanation for the G0/G1 block that was induced by SCR130 and an indicator for preferring HR instead of NHEJ 51 , which could explain why remaining DNA damages in γH2AX assay were unaffected by SCR130 treatment.”
Ilyina, T. S. (2022) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416822030065 · Cited by 4
Pozo-Agundo, E., Álvarez-González, M., Rivera-García, I., García-de-la-Fuente, V., Martino, A. D., Tejedor, J. R., de Vicente, J. C., Rodrigo, J. P., Garcia-Pedrero, J. M., & Álvarez‐Fernández, M. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102417 · Cited by 2
“Interestingly, MASTL has been proposed to positively regulate homologous recombination (HR) repair[7], which raises the possibility it might indirectly suppress NHEJ, as suggested for p21[52].”
Ilyina, T. S. (2022) · Molecular Genetics Microbiology and Virology (Russian) · doi:10.17116/molgen20224003113 · Cited by 2
Igotti, M. V., Gnedina, O. O., Morshneva, A. V., Svetlikova, S. B., & Pospelov, V. A. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0249
“Recent data show that the p21Waf1-deficient cells exhibit an increased NHEJ activity following the treatment with the DSBs-inducing agent adriamycin suggesting that p21Waf1 negatively regulates DSBs’ repair pathway (Mauro et al., 2012).”
BackgroundInfluentialCharacterization of NEK10 Tyrosine Kinase Activity in the Cellular Response to DNA Damage
Haider, N. (2018) · TSpace (University of Toronto) · Cited by 1
Study of the role of the cyclin-dependent kinase inhibitor p21Waf1/Cip1 in cellular senescence
Zapata-Bodalo, I. (2022) · theses.fr (ABES) · doi:10.70675/db01e49aza2daz4404za0f1za3db90231ce9
Copper-Imidazopyridines Activate P53 and Cause Apoptosis in A549 Lung Cancer CellsPreprint
Harmse, L., Mangena, Z., Martins-Furness, C., & Eyk, A. D. V. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4900406
Kitano, T., Zhu, Z., Minami, N., Orino, K., & Yoshikawa, Y. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1570720
Metadata
- Authors
- Mauro, M., Rego, M. A., Boisvert, R. A., Esashi, F., Cavallo, F., Jasin, M., & Howlett, N. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Howlett, Niall G.
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-25
- Volume
- 40
- Issue
- 17
- Pages
- 8348-8360
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC3458556
- OpenAlex
- W2101230738
- Cited by
- 56
- References
- 41
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 2 · 2015: 3 · 2014: 7 · 2013: 4
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Journal of Media Literacy Education (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Science Foundation (1004057)
- Wellcome Trust (101009)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL101977, R21HL095991)
- National Center for Research Resources (P20RR016457)
- Office of Experimental Program to Stimulate Competitive Research (1004057)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- p21, DNA double-strand break repair, homologous recombination, non-homologous end joining, DNA-PKcs phosphorylation, MRE11, cyclin-dependent kinases, sister chromatid exchange, chromosome stability, chromatid aberrations, DNA damage hypersensitivity
- MeSH terms
- MRE11 Homologue Protein, Animals, Camptothecin, Cross-Linking Reagents, DNA Repair, DNA Replication, DNA-Binding Proteins, Etoposide, HeLa Cells, Humans, Phosphorylation, Mitomycin, BRCA2 Protein, Chromosomal Instability, HCT116 Cells, DNA Repair Enzymes, Cyclin-Dependent Kinase Inhibitor p21, Mice, DNA Breaks, Double-Stranded, Topoisomerase Inhibitors, G1 Phase Cell Cycle Checkpoints, DNA End-Joining Repair, Recombinational DNA Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.